Wall Street Journal Reported Wednesday Carl Icahn Has More Than 8% Stake in Beverage-Can Maker Crown Holdings,
https://www.wsj.com/articles/carl-icahn-has-more-than-8-stake-in-beverage-can-maker-crown-holdings-11667435859
Accenture, Hewlett Packard Enterprise And 2 Other Stocks Insiders Are Selling
The Nasdaq Composite declined by over 100 points on Monday. Investors, meanwhile, focused on some notable insider trades.
$8.2 Million Bet On This Penny Stock? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones closed higher by more than 800 points on Friday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Guardforce AI 13G Filing From Streeterville Capital Shows 9.99% Passive Stake In Co.
FOOTNOTES
* Reporting Person Streeterville Capital LLC (“Streeterville”) has rights under a Convertible Promissory Note to own an
Musk Hasn’t Sold More Tesla Shares To Fund $44B Twitter Deal: Could Overhang Be Gone?
The long-awaited, $44 billion deal between Twitter Inc.
$2 Million Bet On FB Financial? 3 Stocks Insiders Are Buying
Although US stocks closed higher on Monday, there were a few notable insider trades.
Astellas to Invest a Total of $50M to acquire 15% of Taysha Gene Therapies
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Taysha Gene Therapies, Inc. (NASDAQ: TSHA, CEO: RA Session II, "Taysha") today announced a strategic investment to support the advancement of Taysha's adeno-associated virus (AAV) gene therapy development programs for the treatment of Rett syndrome and GAN.